Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Influenza
Biotech
RQ nabs $115M to advance flu prevention antiviral
Amid a bustling fundraising week for biotechs, RQ Bio is adding $115 million to its coffers to advance a long-acting antibody for flu prevention.
Eric Sagonowsky
Jun 24, 2026 9:43am
FDA appears less prickly toward Moderna mRNA flu shot
Jun 16, 2026 2:46pm
Traws defers midphase flu study after negative regulatory review
Jun 15, 2026 9:19am
Sanofi abandons attempt to develop mRNA seasonal flu vaccine
Jan 29, 2026 10:26am
CEPI to fund Moderna's pandemic flu trial after HHS walked away
Dec 18, 2025 9:40am
Merck pays $9.2B for owner of flu antiviral J&J rejected
Nov 14, 2025 8:25am
